Dehydrocorydaline exerts anti-metastatic potential via suppression of MMPs and Bcl-2 signaling in NSCLC cells. Dehydrocorydaline stimulates p38 MAPK activation, which can enhance heterodimerization of MyoD and E proteins, thus resulting in MyoD activation and myoblast differentiation. Dehydrocorydaline shows antiplatelet effects, it inhibits thrombin-induced platelet aggregation in a low dose ( IC50= 34.914 ug/mL). Dehydrocorydaline has anti-inflammatory and antinociceptive effects. Dehydrocorydaline inhibits MCF-7 cell proliferation by inducing apoptosis mediated by regulating Bax/Bcl-2, activating caspases as well as cleaving PARP.
Specifications and Purity: 10mM in DMSO
Molecular Formula: C22H24NO4
Molecular Weight: 366.43
PubChem CID: 34781
Isomeric SMILES: CC1=C2C=CC(=C(C2=C[N+]3=C1C4=CC(=C(C=C4CC3)OC)OC)OC)OC
- UPC:
- 41105902
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- D423083-1ml
- CAS:
- 30045-16-0
- Product Size:
- 1ml
akash.verma@cenmed.com
(732) 447-1115





